Immunization of pregnant cows with Stx2 induces high levels of specific colostral antibodies able to neutralize the pathogenicity of Stx2-producing E. coli O157:H7.

ALBANESE ADRIANA; RABINOVITZ BETTINA C; FERNANDEZ BRANDO ROMINA; PALERMO MARINA; CATALDI ANGEL; MERCADO ELSA; 25.PISTONE CREYDT V, NÚÑEZ P, ZOTTA E, IBARRA C

Boston

Simposio; . VTEC2015: 9th Triennal International Symposium on Shiga Toxin (Verocytotoxin)-producing Escherichia coli infections.; 2015

VTEC2015

<!-- /* Font Definitions */@font-face{font-family:Arial;panose-1:2 11 6 4 2 2 2 2 2 4;mso-font-charset:0;mso-generic-font-family:auto;mso-font-pitch:variable;mso-font-signature:-536859905 -1073711037 9 0 511 0;}@font-face{font-family:"Cambria Math";panose-1:2 4 5 3 5 4 6 3 2 4;mso-font-charset:0;mso-generic-font-family:auto;mso-font-pitch:variable;mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face{font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;mso-font-charset:0;mso-generic-font-family:auto;mso-font-pitch:variable;mso-font-signature:-520092929 1073786111 9 0 415 0;}@font-face{font-family:"MS ??";panose-1:0 0 0 0 0 0 0 0 0 0;mso-font-alt:"MS Mincho";mso-font-charset:128;mso-generic-font-family:auto;mso-font-format:other;mso-font-pitch:variable;mso-font-signature:0 134676480 16 0 131072 0;}@font-face{font-family:Arial-BoldMT;panose-1:0 0 0 0 0 0 0 0 0 0;mso-font-alt:Arial;mso-font-charset:77;mso-generic-font-family:auto;mso-font-format:other;mso-font-pitch:auto;mso-font-signature:3 0 0 0 1 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal{mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"";margin:0cm;margin-bottom:.0001pt;mso-pagination:widow-orphan;font-size:12.0pt;font-family:Calibri;mso-fareast-font-family:"MS ??";mso-bidi-font-family:"Times New Roman";}.MsoChpDefault{mso-style-type:export-only;mso-default-props:yes;font-size:11.0pt;mso-ansi-font-size:11.0pt;mso-bidi-font-size:11.0pt;font-family:Calibri;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:ES;mso-fareast-language:EN-US;}.MsoPapDefault{mso-style-type:export-only;margin-bottom:10.0pt;line-height:115%;}@page WordSection1{size:612.0pt 792.0pt;margin:35.45pt 59.15pt 2.0cm 63.8pt;mso-header-margin:35.4pt;mso-footer-margin:35.4pt;mso-paper-source:0;}div.WordSection1{page:WordSection1;}-->Introduction. Enterohemorrhagic Escherichiacoli (EHEC) O157:H7 is responsible for intestinal disease and hemolyticuremic syndrome (HUS), a serious systemic complication frequently associatedwith Shiga toxin type 2 (Stx2). The aim of this study was to evaluate theability of bovine hyperimmune colostral antibody against Stx2 to prevent thepathogenicity of EHEC O157:H7. Methods. Three pregnant cows were intramuscular immunized at 40and 20 days before delivery with 100 mg of inactivated Stx2 mixed with 1 mL of mineral oil-based adjuvant.Colostrum was obtained within the first 24 h after parturition and the IgGs werepurified by affinity chromatography. The neutralizing capacity of Stx2 wasdetermined for viability assay in Vero and HTC-8 cell lines. Colon loops ofmale SD rats were incubated overnight with either Stx2 or Stx2 pre-incubated 30min at 37ºC with IgG from colostrum of immunized or non-immunized cows. Colon loops were inoculated with EHEC O157:H7 grown toexponential phase with or without preincubation with hyperimmune colostral IgG.Colon loops were rapidly removed, measured for length and fluid content, and analyzedon optic microscopy. BalB-c weaned mice were inoculated intragastrically with lethaldose (2.4x1010 CFU/Kg) of EHEC O157:H7. Some mice received one ortwo doses of IgGs (7.5 mg/dose) 1 h before and2 h after EHEC challenge. The EHEC O157:H7 used was the strain 125/99 Stx2+ belonging tothe hypervirulent clade 8 isolated from a pediatric HUS patient. Results andDiscussion. High titers (1/5000) of purifiedIgG antibody against Stx2 was observed in vaccinated cows using Vero and HCT-8 assays. In addition,rat colon loops treated with Stx2 or EHECO157:H7 previously incubated withhyperimmune colostral IgG prevent secretion of bloody fluid and histologicalalterations observed in colon loops inoculated with EHEC O157:H7. Preliminary results treating BalB-c weaned mice with hyperimmunecolostral IgG by oral route showed a dose-dependent partial protection againsta lethal bacterial challenge. Implications. These results suggest that the presence of neutralizinganti-Stx2 antibodies in hyperimmune bovine colostrum could be used asnutraceutics in children at risk of HUS.